Your browser doesn't support javascript.
loading
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control design.
Reynolds, Matthew W; Secora, Alex; Joules, Alice; Albert, Lisa; Brinkley, Emma; Kwon, Tom; Mack, Christina; Toovey, Stephen; Dreyer, Nancy A.
Afiliação
  • Reynolds MW; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Secora A; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Joules A; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Albert L; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Brinkley E; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Kwon T; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Mack C; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
  • Toovey S; Pegasus Research, Neuschwaendistrasse 6, Engelberg, 6390, Switzerland.
  • Dreyer NA; IQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139, USA.
J Comp Eff Res ; 11(16): 1161-1172, 2022 11.
Article em En | MEDLINE | ID: mdl-36148919
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article